Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Safety Study of 3 Different Bowel Cleansing Preparations

ClinicalTrials.gov ID: NCT01501513

Public ClinicalTrials.gov record NCT01501513. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety, Tolerance and Efficacy Evaluation of 3 Different Bowel Cleansing Preparations in Adult Subjects, Including the Elderly and Subjects With Hepatic or Renal Insufficiency

Study identification

NCT ID
NCT01501513
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Braintree Laboratories
Industry
Enrollment
541 participants

Conditions and interventions

Interventions

  • PEG-3350 based bowel preparation Drug
  • BLI800 approved preparation regimen Drug
  • BLI800 investigational preparation regimen Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2011
Primary completion
Mar 3, 2013
Completion
Mar 3, 2013
Last update posted
Jan 16, 2024

2011 – 2013

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
16
Facility City State ZIP Site status
University of South Alabama Mobile Alabama 36693
Advanced Clinical Research Institute Anaheim California 92801
Mayo Clinic Jacksonville Jacksonville Florida 32224
Borland-Groover Clinic Jacksonville Florida 32256
Miami Research Associates South Miami Florida 33143
Indiana University Indianapolis Indiana 46202
Delta Research Partners Monroe Louisiana 71201
Commonwealth Clinical Studies Brockton Massachusetts 02302
Gastrointestinal Associates Jackson Mississippi 39202
Asheville Gastroenterology Associates Asheville North Carolina 28801
Carolina Digestive Health Associates Charlotte North Carolina 28262
Wake Research Associates Raleigh North Carolina 27612
Consultants for Clinical Research Cincinnati Ohio 45219
Northwest Gastroenterology Portland Oregon 97210
ClinSearch Chattanooga Tennessee 37421
Franklin Gastroenterology Franklin Tennessee 37067
Charlottesville Medical Research Charlottesville Virginia 22911

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01501513, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2024 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01501513 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →